Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods

BackgroundCognitive side-effects are an important reason for the limited use of electroconvulsive therapy (ECT). Cognitive side-effects are heterogeneous and occur frequently in older persons. To date, insight into these side-effects is hampered due to inconsistencies in study designs and small samp...

Descrición completa

Detalles Bibliográficos

Principais autores:	Marieke J. Henstra, Thomas C. Feenstra, Rob M. Kok, Harm-Pieter Spaans, Eric van Exel, Annemiek Dols, Mardien Oudega, Anton C. M. Vergouwen, Adriano van der Loo, Pierre M. Bet, Stephan A. Loer, Merijn Eikelenboom, Pascal Sienaert, Simon Lambrichts, Filip Bouckaert, Judith E. Bosmans, Nathalie van der Velde, Aartjan T. F. Beekman, Max L. Stek, Didi Rhebergen
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Psychiatry
Assuntos:	electroconvulsive therapy (ECT) late life depression (LLD) cognitive side effects interictal delirium rivastigmine cholinesterase inhibitor
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fpsyt.2022.953686/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!